Evaluation Study of SPOTme® Skin Cancer Screenings

NCT03564769 | Completed

• 1 other identifier: 17-1668
• Study Type: interventional
• Target: 431
• Locations: 1 country
• Sites: 1

Brief Summary

This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.

Conditions

Skin Cancer

Keywords

screening

Outcome Measures

Primary Outcomes (1)

• Completion of a physician skin examination

  Self-report of a physician skin examination will be defined as a health care provider examining the patient's entire body for any sign of skin cancer during the period following patient's receipt of an AAD SPOTme® skin cancer screening to the baseline assessment.

  Baseline

Secondary Outcomes (3)

• Completion of a physician skin examination

  6 months

• Patient thorough skin self-examination (TSSE)

  6 months

• Patient attitude towards sun protection

  6 months

Study Arms (2)

Intervention Arm 1

EXPERIMENTAL

Individuals randomized to intervention group 1 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 AND will receive additional skin cancer screening educational materials.

Behavioral: Intervention Arm; Other: AAD SPOTmeⓇ skin cancer screening

Intervention Arm 2

EXPERIMENTAL

Individuals randomized to intervention group 2 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 only.

Other: AAD SPOTmeⓇ skin cancer screening

Interventions

Intervention Arm BEHAVIORAL

Individuals randomized to the intervention group will receive skin cancer screening educational materials.

Intervention Arm 1

AAD SPOTmeⓇ skin cancer screening OTHER

All study participants will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017.

Intervention Arm 1; Intervention Arm 2

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participated in the American Academy of Dermatology national screening program in 2016 or 2017
• Have a presumptive diagnosis (screening, non-confirmed) of melanoma
• Have provided the AAD with permission to be re-contacted
• Have provided the AAD with an email address
• Aged 18 years or older
• Able to read English

You may not qualify if:

• None

Sponsors & Collaborators

• Harvard School of Public Health (HSPH): lead
• American Academy of Dermatology (AAD): collaborator

Study Sites (1)

Harvard TH Chan School of Public Health

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Skin Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Alan Geller, MPH, RN

  Harvard TH Chan School of Public Health

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MPH, RN

Study Record Dates

• First Submitted: December 6, 2017
• First Posted: June 21, 2018
• Study Start: December 1, 2017
• Primary Completion: October 1, 2018
• Study Completion: June 1, 2019
• Last Updated: August 13, 2019

Record last verified: 2019-08

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)